BridgeMD
New treatment option for Percutaneous Internal Ring Suturing
Official title Comparison of the Postoperative Analgesic Effects of RSB and CEB in Pediatric Patients Scheduled for Percutaneous Internal Ring Suturing
ClinicalTrials.gov ID: NCT07147062
What this study is testing
- What it's testing
- Inguinal hernia is one of the most common surgical pathologies in children, and the minimally invasive percutaneous internal ring suturing (PIRS) technique is widely preferred. By providing effective pain control, nerve blocks reduce postoperative opioid requirements, thereby minimising opioid-related adverse effects and lowering the risk of pulmonary and cardiovascular complications.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 8
You may be able to join if
- Patients aged between 1 and 8 years
- ASA physical status I-II
- Patients who underwent PIRS surgery in the operating room and received either a rectus sheath block or a caudal epidural block
You likely can't join if
- Patients younger than 1 year or older than 8 years
- ASA physical status ≥ III
- History of bleeding diathesis
The study team makes the final eligibility decision.
Where it's taking place
- Altındağ, Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year to 8 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Altındağ, Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.